Cargando…
Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathway
In cancer, glycolysis driving enzymes and their regulating microRNAs are one of the key focus of oncology research lately. The glycolytic enzyme hexokinase 2 (HK2) is crucial for the Warburg effect in human glioma, the most common malignant brain tumor. In the present study, we studied the tumorigen...
Autores principales: | Liu, Hui, Liu, Nan, Cheng, Yingduan, Jin, Weilin, Zhang, Pengxing, Wang, Xin, Yang, Hongwei, Xu, Xiaoshan, Wang, Zhen, Tu, Yanyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722312/ https://www.ncbi.nlm.nih.gov/pubmed/29220380 http://dx.doi.org/10.1371/journal.pone.0189353 |
Ejemplares similares
-
SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistance
por: Wang, Zhen, et al.
Publicado: (2017) -
MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9
por: Liu, Nan, et al.
Publicado: (2016) -
Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
por: Wang, Huanan, et al.
Publicado: (2016) -
Genetic variants of SOX9 contribute to susceptibility of gliomas among Chinese population
por: Wang, Liang, et al.
Publicado: (2016) -
A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors
por: Li, Ruiqi, et al.
Publicado: (2022)